Skip to content

Public FDA record

Z-2152-2014: VIDAS TPSA, in vitro diagnostic, for use as an automated quantitative measurement of prostate specific an

Recall record Z-2152-2014 for BioMerieux SA. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2152-2014
Company in FDA record
BioMerieux SA
FDA classification date
Aug 6, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product is not approved or authorized for distribution in the US.

Source facts

Action
A letter was issued on October 14, 2013 to consignees requesting the consignee to check their stock and destroy all kits of the VIDAS TPSA ref. 30428. The letter also requested that the consignee notify their accounts of the recall. An acknowledgment form was also included with the letter which is to be returned to BioMerieux.
Initiated
2013-10-14
Root cause
Packaging process control
Terminated
2017-08-28
Distribution
FL, LA, MI, MS, NV, OH, OK, TN, TX
Recall number
Z-2152-2014
Recall status
Terminated
CDRH record ID
128597
FDA classified
2014-08-06
Recall event number
68749

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗